For all SNPs considered by meta VC-TWAS of genes ZNF234 and TOMM40 for studying AD clinical diagnosis, we colocalized the meta GWAS results for AD clinical diagnosis with ROS/MAP and Mayo Clinic cohorts and the corresponding DPR weight (i.e., cis-eQTL effect size) magnitude. This evidence concerns the gene ZNF234 and Alzheimer disease.